World-wide medical news for clinical use. Contributions edited by Dr.A.Franklin MBBS(Lond)Dip.Phys.Med (UK) DPH & DIH(Tor.)LMC(C) FLEx(USA) Fellow Med.Soc.London
12 February 2014
SPIRONOLACTONE & EPLERENONE in PRIMARY ALDOSTERONISM (CONN SYNDROME)
Integr Blood Press Control. 2013 Oct 4;6:129-138. eCollection 2013.
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine.
AUSTRALIA: Melbourne. PROF J.W.FUNDER
Spironolactone was first developed over 50 years ago as a potent mineralocorticoid receptor (MR) antagonist with undesirable side effects; it was followed a decade ago by eplerenone, which is less potent but much more MR-specific. From a marginal role as a potassium-sparing diuretic, spironolactone was shown to be an extraordinarily effective adjunctive agent in the treatment of progressive heart failure, as was eplerenone in subsequent heart failure trials. Neither acts as an aldosterone antagonist in the heart as the cardiac MR are occupied by cortisol, which becomes an aldosterone mimic in conditions of tissue damage. The accepted term "MR antagonist", (as opposed to "aldosterone antagonist" or, worse, "aldosterone blocker"), should be retained, despite the demonstration that they act not to deny agonist access but as inverse agonists. The prevalence of primary aldosteronism is now recognized as accounting for about 10% of hypertension, with recent evidence suggesting that this figure may be considerably higher: in over two thirds of cases of primary aldosteronism therapy including MR antagonists is standard of care. MR antagonists are safe and vasoprotective in uncomplicated essential hypertension, even in diabetics, and at low doses they also specifically lower blood pressure in patients with so-called resistant hypertension. Nowhere are more than 1% of patients with primary aldosteronism ever diagnosed and specifically treated. Given the higher risk profile in patients with primary aldosteronism than that of age, sex, and blood pressure matched essential hypertension, on public health grounds alone the guidelines for first-line treatment of all hypertension should mandate inclusion of a low-dose MR antagonist.
KEYWORDS:
eplerenone, inverse agonists, primary aldosteronism, public health, spironolactone
PMID:
24133375
[PubMed - as supplied by publisher]
PMCID:
PMC3796852
Free PMC Article
UK CORK & LEATHER INSOLE
www.ggfootcare.co.uk
Leather upper Cork Insole (CORK DIFFICULT TO FIND)
These are chemical free vegetable tanned genuine leather upper insoles, with first class natural soft cork. combining these quality materials you get a comfortable, soft and breathable insole. Suitable for any type of footwear.
.Genuine soft Leather upper
.Natural soft cork backing for extra comfort
Available in sizes:
UK 3/4, 5/6, 7, 8/9 10/11, 12/13
Eur Sizes 36/37, 38/39, 40/41, 42/43, 44/45, 46/47,
SOLD IN PAIRS
Our Price: £4.00 (+ delivery)
Subscribe to:
Posts (Atom)